Joe K. Gerald, MD, PhD

Associate Professor, Public Health
Program Director, Public Health Policy & Management
Associate Research Scientist, A2DRC

Research Areas:

Cost-effectiveness of respiratory-related interventions in school-based asthma management and tuberculosis screening

Selected Publications


Gerald JK. "Benefits of Stock Epinephrine Likely Misestimated." JAMA Pediatr. 2019.

Gerald JK, Fisher JM, Brown MA, et al. "School-supervised use of a once-daily inhaled corticosteroid regimen: A cluster randomized trial." J. Allergy Clin. Immunol.. 2019;143(2):755-764. PMCID: PMC6628704  PMID: 30118728

Verhougstraete MP, Gerald JK, Gerba CP, Reynolds KA. "Cost-benefit of point-of-use devices for lead reduction." Environ. Res.. 2019;171:260-265.

Gerald JK, Hallmark B, Billheimer D, Martinez FD, Gerald LB. "Are Latino children of Mexican origin with asthma less responsive to inhaled corticosteroids than white children?" J Allergy Clin Immunol Pract. 2019.


Goodwin JL, Gerald LB, Johnson JLH, Gerald JK. "Use of a disposable valved-holding chamber (spacer) in a school-based asthma trial." J Allergy Clin Immunol Pract. 2018;6(1):307-309. PMCID: PMC5760365  PMID: 28970085